The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGLIF.L Regulatory News (GLIF)

  • There is currently no data for GLIF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

30 Sep 2020 15:44

RNS Number : 6541A
GLI Finance Limited
30 September 2020
 

 

 

30 September 2020

 

GLI Finance Limited

 

("the Group" or "GLI")

 

Interim Report and Unaudited Condensed Consolidated Finance Statements

 

For the six month period ended 30 June 2020

 

 

Andy Whelan, Chief Executive Officer of GLI Finance Limited, commented:

"The Covid-19 pandemic negatively impacted our performance for the first half of 2020, contributing to an operating loss of £0.5m. We were able to close just a few new loans during this period, largely because we were unable to carry out site visits which is key to us managing our lending risk. We have also taken a further material write-down on the FinTech Ventures portfolio with a net write down of £4.2m. The FinTech sector continues to grow strongly, but increased competition, coupled with the impact of Covid-19 is making it difficult for smaller players, particularly those that are loss making, to raise further equity."

 

"Despite this, our overall performance was more positive than first anticipated at the beginning of March, with the receipt of some large exit fees and positive developments on certain assets that had previously been impaired. We have implemented Group cost savings following the onset of Covid-19 which on an annual basis equate to circa £700k and we expect to see the full impact of this in the second half of 2020."

 

"As we exited lockdown, the Sancus business bounced back and we have seen a backlog of loan transactions close. We are witnessing lots of new loan origination as other lenders pull back from the market or sadly have ceased trading, and in the UK especially, we have a large pipeline of loans. I would like to thank all shareholders for their continued support during this period of change."

 

"Finally, we are pleased to announce that we are in negotiations with Somerston Fintech Limited (details below) the Company's largest shareholder, which should hopefully provide all stakeholders with the confidence that the Board is focussed on ensuring the Company is appropriately capitalised to maximise shareholder value".

 

Group

 

· Group revenue for the half year was £5.5m (H1 2019: £7.1m) the reduction as expected following the runoff of the BMS UK Fund and on balance sheet loans, and lower transaction revenue from the impact of Covid-19;

· Group operating loss for the half year was £0.5m (H1 2019: loss £0.1m) with reductions in operating costs and IFRS9 adjustments, netting off the impact of a decline in revenue;

· Group retained loss for the half year was £6.5m (H1 2019: loss £6.1m) negatively impacted by Covid-19 with further write downs on the FinTech Ventures portfolio and the elimination of the implied goodwill in Sancus IOM Holdings Limited due to current market conditions;

· Focus on cost control has continued into 2020 with a further reduction of headcount from 34 to 29. Additional cost saving initiatives have been put in place following Covid-19, the full effect of these will not be seen until the second half of the year, however annualised we expect this to be circa £700k;

· The Zero Dividend Preference shares ("ZDPs") were extended for a further year on 5 December 2019, with buy backs during the first half of the year reducing the balance for repayment on 5 December 2020 to £13.1m;

· The Company has certain liabilities that fall due in the next 12 months which are noted below:

 

· The final capital entitlement of the Company's ZDP shares is £13.1m, which is repayable on 5 December 2020;

· The facility with Honeycomb Investment Trust plc ("HIT"), which as at 30 June 2020 was £40.8m drawn, expires on 28 January 2021; and

· The £10m bond is repayable on 30 June 2021 (the "GLI Bonds").

 

The Company has been considering its options regarding these liabilities, which include their repayment and/or extension, and is considering:

· an equity fundraising of up to £2.5m at 2.5p, which represents a premium of 11% to the Company's closing mid-market share price on 29 September 2020, £1.5m of which would be underwritten by Somerston FinTech Limited ("Somerston"), and which would also be supported by Philip J Milton & Company Plc, both major shareholders in the Company; and

· the issue of up to £15m of new corporate bonds, with a coupon of 7% and a maturity date in 2026 of which Somerston would subscribe for £6m (together, the "Proposed Fundraising"). Subscribers of the new bonds would be issued with warrants over ordinary shares at an exercise price of 2.5p, representing 0.25% of the Company's ordinary shares for each £100,000 subscribed.

 

Somerston's participation in the Proposed Fundraising would be subject to due diligence.

 

The proceeds of the Proposed Fundraising would be used to repay the GLI Bonds and the Company expects that it would use its own cash resources to fund any shortfall. In conjunction with the Proposed Fundraising, the Company intends to seek a two-year extension to the repayment date of the Company's ZDP shares on terms to be agreed and we are engaged with HIT regarding the extension and increase of the HIT facility.

 

The Proposed Fundraising together with the proposals outlined above are subject to further consideration by the Board, consultation with the relevant stakeholders, including ordinary shareholders, ZDP shareholders, bondholders and HIT and, if pursued, relevant shareholder and regulatory approvals and consents. Accordingly, there can be no certainty that the Proposed Fundraising or the other proposals will proceed.

 

Sancus BMS

 

· Proforma operating profit* for the first half of the year was £0.1m (H1 2019: £0.3m). The reduction is a consequence of lower interest income (as we downsize on balance sheet exposure) and a decrease in arrangement and commitment fees as new loan origination was severely hampered by Covid-19;

· We continue to divest assets where return on capital, on a risk adjusted basis, is below other areas of the business in line with our objective of efficient capital allocation. This has led to a gradual reduction in our SME lending activities where loans tend to deserve a higher risk weighting and require significant use of our own balance sheet. We have redirected resources to our core asset backed secured lending activities where third-party funding is more accessible and our balance sheet less utilised;

· In line with our focus to improve asset efficiency and the quality of our financials, for the first half of the year proforma on-balance sheet loan exposure reduced by 32% compared to H1 2019, with revenue falling by far less, 20% from £6.8m to £5.4m;

· Costs have been managed well during the period with a £0.5m (18%) reduction in operating expenses;

· During H1 2020 over £50m of loans have been repaid with the Sancus team working continually during the lockdown;

· We continue to diversify and broaden our sources of capital and lending capacity. As at 30 June 2020, Sancus had loans outstanding of £167m with Co-Funders providing £158m, equating to a co-funding ratio of 95% (up from 92% at June 2019); and

· Business in the UK and Ireland continues to expand with the pipeline for these key growth markets strong and although H1 2020 was impacted by Covid-19, the second half of the year is already looking a lot more positive.

 

* A proforma reconciliation to Statutory Results is noted in Table 1 and Table 3.

 

 

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation (No 596/2014)

 

 

Enquires:

 

 

GLI Finance Limited via Instinctif Partners

 

Andy Whelan

 

 

Nominated Adviser and Broker

Liberum Capital Limited +44 (0)203 100 2000

 

Chris Clarke

Edward Thomas

 

 

Public Relations Adviser

Instinctif Partners

 

Lewis Hill +44 (0) 7837 674 600

Tim Linacre +44 (0) 7949 939 237

 

 

 

CHAIRMAN'S STATEMENT

 

Positioning the business for the future

 

Our focus remains on maximising the value potential of our two distinct business units, whilst recognising that Sancus BMS is the key for GLI's future.

 

Sancus BMS comprises the Group's property backed and SME lending businesses. FinTech Ventures represents the Group's investments in a portfolio of SME focussed lending platforms. Over the last few years, we have seen the valuation of FinTech Ventures become a much smaller part of the Group's assets as certain platforms within the portfolio have not been successful and numerous valuations in the sector have reduced. We are in a difficult position as a minority investor with limited financial resources to continue to support the platforms, but we continue to work hard to maximise the value from this portfolio. We have taken a further net write down of £4.2m in the period as we remain cautious on the impact that Covid-19 has had on the portfolio which at 30 June 2020 is now valued at £2.2m.

 

Sancus BMS is our core trading business and has fared relatively well despite the disruption caused by Covid-19, successfully returning over £50m to co-funders during this period. This in turn reduced our loan book by 11% from £188m at 30 June 2019 to £167m at 30 June 2020. We have seen a healthy pipeline of loans since coming out of lockdown, and expect our loan book to grow once more as the market picks up. Sancus BMS revenue on a statutory reporting basis has reduced to £5.4m for the six months ended 30 June 2020 compared to £6.8m in the prior period. £2.3m of this revenue related to Sancus Loans Limited ("SLL") which increased by 41% in comparison to the prior period as the loan book grew from £33.9m to £41.2m. In our view, to show the true economic performance of the Group, all Co-Funders should be assessed in the same way. However, as SLL is 100% owned by Sancus BMS Group Limited (as it was required to be set up as an SPV for the HIT facility) it is consolidated into the Group's results. In our proforma statements on Table 1 the SLL results have been deducted from the consolidated statement of comprehensive income ("SOCI") and the consolidated statement of financial position ("SOFP") and we show the results on a net basis which is the same for all our other syndicated lending arrangements.

 

Sancus BMS revenue on a proforma basis has fallen by 34% (£1.8m) in comparison to H1 2019. £1.1m of this related to interest income which is expected to decrease further over the remainder of this year as we reduce our on-balance sheet loan book. This is in line with our long-term strategy to increase return on tangible assets over time with reduced on-balance sheet risk exposure. Fees and Other Income are 25% down on H1 2019 (£0.9m) which is the main area where we saw Covid-19 impact our results. Looking forward we expect this to be our growth revenue line as we build in more and more exit fees over time and as the deal flow comes back from lockdown, arrangement and commitment fees will pick up.

 

We continue to see encouraging growth in Co-Funder appetite, which includes the £45m HIT facility that was launched in January 2018, of which the loan balance at the end of June 2020 was £40.8m. In addition to this facility and regular participation by Co-Funders, we also have the Sancus Loan Note programme that has proven very successful and provides Co-Funders with the option of participating in a wider pool of loans with a fixed rate of return. This diversification of funding has allowed us to grow the Sancus BMS loan book and we continue to look at other similar debt providers to aid expansion plans.

 

The Company's Liabilities

 

In December 2019 the ZDPs were extended for a further year at an increased coupon of 8% following shareholder approval. This extension was sought as the timing of the repayment of some of the larger loans on our balance sheet has been longer than previously expected. As part of the extension we noted our intention to make a tender offer in March 2020 and on 6 March 2020, shareholder approval was received to buyback 25% of the total ZDP shares in issue (excluding treasury shares) (of which 22% was taken up) and to approve a loan swap in exchange for a shareholder's entire holding of 621,586 ZDP shares. This represented £3.8m in cash repaid to ZDP shareholders and a loan transfer for £0.8m. In June 2020, a further 170,000 ZDP shares were purchased in the market reducing the final capital entitlement due on 5 December 2020 to £13.1m.

 

The Company has certain liabilities that fall due in the next 12 months which are noted below:

· the final capital entitlement of the Company's ZDP shares is £13.1m, which is repayable on 5 December 2020;

· the facility with Honeycomb Investment Trust plc ("HIT"), which as at 30 June 2020 was £40.8m drawn, expires on 28 January 2021; and

· the £10m bond is repayable on 30 June 2021 (the "GLI Bonds").

 

Based on current cash reserves plus the loan maturity profiles of the Sancus and BMS Fund loan books, our cash flow forecasts indicate there would be sufficient cash available to continue on a Going Concern basis. However, as we have seen in the past, timings of the repayment of loans can vary and deviate from expectations as development loans may run over and in the case of the BMS Fund, the refinance of some of the loans may not occur as planned. In the past year especially, we have seen this occur with the impact of Brexit playing some part, but this risk is now heightened by Covid-19.

 

Based on the Company's liabilities and taking into account the various possible outcomes and assumptions as part of the Going Concern model, they constitute a material uncertainty that may cast significant doubt over the Company's and Group's ability to continue as a Going Concern, such that it may be unable to realise its assets and discharge its liabilities in the normal course of business. Refer Note 2(c) for further details.

 

The Company has been considering its options regarding these liabilities, which include their repayment and/or extension, and is considering:

 

· an equity fundraising of up to £2.5m at 2.5p which represents a premium of 11% to the Company's closing mid-market share price on 29 September 2020, £1.5m of which would be underwritten by Somerston FinTech Limited ("Somerston"), and which would also be supported by Philip J Milton & Company Plc, both major shareholders in the Company; and

· the issue of up to £15m of new corporate bonds, with a coupon of 7% and a maturity date in 2026 of which Somerston would subscribe for £6m (together, the "Proposed Fundraising"). Subscribers of the new bonds would be issued with warrants over ordinary shares at an exercise price of 2.5p, representing 0.25% of the Company's ordinary shares for each £100,000 subscribed.

 

Somerston's participation in the Proposed Fundraising would be subject to due diligence.

 

The proceeds of the Proposed Fundraising would be used to repay the GLI Bonds and the Company expects that it would use its own cash resources to fund any shortfall. In conjunction with the Proposed Fundraising, the Company intends to seek a two-year extension to the repayment date of the Company's ZDP shares on terms to be agreed and we are engaged with HIT regarding the extension and increase of the HIT facility.

 

The Proposed Fundraising together with the proposals outlined above are subject to further consideration by the Board, consultation with the relevant stakeholders, including ordinary shareholders, ZDP shareholders, bondholders and HIT and, if pursued, relevant shareholder and regulatory approvals and consents. Accordingly, there can be no certainty that the Proposed Fundraising or the other proposals will proceed.

 

Covid-19

 

The publication of our full year accounts came amidst the start of the Covid-19 crisis, the World Health Organisation had announced its classification as a global pandemic and all operating jurisdictions were in the early stages of lockdown. We remain unsure as to the pandemic's full impact on the economy and how long the disruption will remain, although it looks as if we face a difficult winter ahead. As lockdown eased during the early summer, we were pleased to see a sharp increase in business activity and enquiries across the Group, encouraged by various government stimulus packages, and we hope activity remains at this level as the latter part of the year unfolds. Recent developments on lockdown rules indicate we still face some challenges in the UK. However, we are more positive on the offshore jurisdictions who are able to control their borders more easily to avoid a second full scale lock down.

The World Bank is forecasting a global contraction of 5.2% this year, which would represent the deepest recession since the Second World War. This combined with increasing tensions between China and USA, the hope of the US economy bouncing back looking increasingly less likely, the weakening of the US Dollar and the turmoil amongst shares in a number of sectors makes for continued uncertainty and large volatility across many asset classes. 

 

Brexit

 

The Brexit transition period ends on 31st December 2020 and the deadline for extension has now passed. Boris Johnson says an agreement on trade must be completed by 15th October 2020, but we still remain unclear as to whether or not we face a "no deal" scenario, which is now becoming increasingly likely.

 

These uncertainties make it very difficult to predict what impact this will have on the UK property lending market. However, Sancus has further tightened its credit processes and is more cautious when reviewing lending proposals. The combination of the pandemic and Brexit in the same year have now made our fears of a global recession a reality with the associated correction in stock and bond markets.

 

However, we do believe that the medium-term benefits will be positive for alternative lenders as banks will step back further from their lending activities as they closely monitor their Tier 1 Capital ratios. In the immediate future, businesses may pause and take a wait and see approach for new projects, however, for already committed projects we expect them to continue to push forward and execute on their plans. In any stressful period, there are arbitrage pricing opportunities and Sancus will seek to benefit from such instability.

 

Overview

 

We have made significant strides to lay the foundation for growth and operational improvements to create and build shareholder value in the Sancus BMS Group. The HIT funding facility, Loan Note and Co-Funder network helps to support this growth, but we are also continuing to secure a steady flow of new Co-Funders due to the attractive risk-adjusted returns that are available on our secured lending opportunities. Cash and Bond yields are at all-time lows and this does not seem likely to change for a considerable period of time. Our focus for the foreseeable future is growing the UK and Irish operations and continuing to expand the offshore jurisdictions.

 

We shall continue carefully managing the FinTech Ventures portfolio and explore options to maximise the return to Shareholders, although we note the continuing challenges on these investments and the extremely poor performance.

 

Dividend and Shareholders

 

In line with our dividend policy, we do not propose to declare a dividend for this period. We expect our investments in Ireland and the UK together with further focus on operational matters to drive cash flow in the coming years. This will allow us to resume the dividend. I am grateful to all our Shareholders who have kept confidence with the Group through what continues to be a challenging period as reflected in the depressed share price. We believe that the share price is trading well below the inherent value of the business and we look forward to seeing it recover in due course on the back of the strong growth delivered by the Executive Team within Sancus BMS.  

 

On behalf of the Board I thank shareholders for their continuing support.

 

 

 

Patrick Firth

Chairman

Date: 30 September 2020

 

CHIEF EXECUTIVE OFFICER'S REVIEW

 

Overview

 

The first half of 2020 saw the business cope well with Covid-19. Although revenue was hampered by a lack of fees from new loans, which is to be expected, all staff continued to work successfully from home during the pandemic and were in close contact with Co-Funders and Borrowers during this time. As Sancus is multi-jurisdictional we saw differing levels of lockdown across the offshore regions. We have benefited from a spread of location risk where in smaller jurisdictions such as Guernsey, Jersey and Gibraltar the lockdown restrictions did not last as long as we have seen in the UK and thus have been able to get back to the "new normal" a little quicker. We ensured that Co-Funders were kept informed of developments within the business and took an empathetic approach with Borrowers who requested either extensions of their loan (if they expired during the period of reporting) or deferred interest payments. This has meant that coming out of the pandemic we have a very positive loan origination pipeline and during H1 we returned over £50m to Co-Funders from the successful repayment of loans.

 

We continue to spend considerable time, energy and focus on the UK and Irish operations to ensure they are well positioned to grow in the coming months and we have started to see these efforts pay off with the UK in particular showing positive signs of growth, particularly with respect to development finance opportunities. We expect we will feel the effects of Brexit in the coming months, but we are doing all we can to prepare in advance, for example, ensuring we are keeping a close eye on our development loans (which are typically riskier than bridging loans) and may rely on building supplies from Europe. We don't expect the remainder of this year to be easy but subject to no further full-scale lockdowns we expect to have a much more positive second half.

 

We continue to work closely with the FinTech Ventures portfolio providing support where we can. During the first half of the year we sold one of our equity positions (and a second one post period end) for £0.4m. It remains a challenging market for many of the platforms to raise capital with Covid-19, which may bring opportunities in the longer term but at the moment we remain cautious and have made the decision to write down the portfolio with a net adjustment of £4.2m.

 

The Group results for the first half of 2020 produced revenue of £5.5m (30 June 2019: £7.1m) and an operating loss of £0.5m (30 June 2019: loss £0.1m). As we go onto explain below, the statutory results include the revenue and debt costs of the HIT facility which saw a significant increase from last June as we have utilised our Co-Funder base to grow the loan book. Revenue decreased year on year, which was expected as we run down our loan book and on balance sheet exposure, largely in the BMS Fund that also has advisory fees linked to AUM, but also due to reduced lending activity during lockdown which impacted transaction fees. The Group net assets have reduced in the period from £40.4m at 31 December 2019, to £33.8m at 30 June 2020 predominantly as a result of the FinTech write down.

 

Cash management and debt costs

The first half of 2020 has seen the continued focus on our future liabilities. We have been managing cash carefully. In addition to the tender offer in March 2020, we have also purchased ZDPs as they became available in the market.

To measure business unit performance, finance costs are allocated to Sancus BMS to recognise its use of the Group's debt facilities in its lending activities. FinTech Ventures is treated as being funded by equity. This allocation best matches the risk profile of each business unit with its capital structure, as well as recognising that interest costs are effectively serviced by interest income from Sancus BMS.

 

Total cost of sales of £3.0m for the period to June 2020 (2019: £2.5m) includes: debt interest costs on the ZDPs and Bond of £1.1m (2019: £0.9m); £1.8m interest on the HIT facility (2019: £1.3m) and broker fees of £0.1m (2019: £0.3m).

 

At the period end, interest bearing debt comprised:

 

· £10m 5-year Bond (7%) matures 30 June 2021, interest paid half yearly;

· £12.6m 2019 ZDPs (8%) income entitlement and principal due on expiry 5 December 2020 (£13.1m); and

· £40.8m HIT facility expires 28 January 2021 (7.25%) (total facility £45m), interest paid monthly.

 

Commentary on the repayment and/or extension plans of the debt instruments listed above are included in the Going Concern commentary in Note 2c.

 

Sancus BMS

 

The Board reviews economic performance in detail using proforma statements. In our view, all Co-Funders should be assessed in the same way. However, as Sancus Loans Limited ("SLL") is 100% owned by Sancus BMS Group Limited (as it was required to be set up as an SPV for the HIT facility) it is consolidated into the Group's results. In our proforma statements the SLL results have been deducted from the consolidated statement of comprehensive income ("SOCI") and the consolidated statement of financial position ("SOFP") noted below and we show the results on a net basis which is the same for all our other Co-Funder arrangements. We show the reconciliation of the proforma statements with accounting statements below.

 

Financial Results for the six months ended 30 June 2020 (Table 1) - Sancus BMS Group

 

Sancus BMS SOCI Proforma Results

30 June 2020

£'000

30 June 2019

£'000

Movement

%

Movement

£'000

Sancus BMS interest on loans

473

1,620

(71%)

(1,147)

Sancus BMS Fees and Other Income

2,662

3,530

(25%)

(868)

Sancus Loans Limited Fees and Other Income

444

271

64%

173

Revenue

3,579

5,421

(34%)

(1,842)

Interest costs

(966)

(891)

(8%)

(75)

Other cost of sales

(71)

(253)

72%

182

Total Cost of Sales

(1,037)

(1,144)

9%

107

Gross profit

2,542

4,277

(41%)

(1,735)

Operating expenses

(2,292)

(2,779)

18%

487

Changes in expected credit losses ("ECLs") (IFRS 9)

(161)

(1,175)

86%

1,014

Net operating profit

89

323

(72%)

(234)

Other net losses

(1,776)

(753)

(136%)

(1,023)

Tax

(67)

(144)

53%

77

Loss for the period

(1,754)

(574)

(206%)

(1,180)

 

 

 

 

 

Reconciliation to SOCI - Revenue

30 June

 2020

£'000

30 June 2019

£'000

Movement

%

Movement

£'000

 

 

 

 

 

 

 

Revenue per proforma Sancus BMS SOCI

3,579

5,421

(34%)

(1,842)

 

Less Sancus Loans Limited Fee and Other Income

(444)

(271)

(64%)

(173)

 

Sancus Loans Limited Revenue

2,280

1,611

42%

669

 

Revenue per Sancus BMS SOCI (Note 3)

5,415

6,761

(20%)

(1,346)

 

 

 

 

 

 

 

Reconciliation to SOCI - Cost of Sales

30 June

 2020

£'000

30 June 2019

£'000

Movement

%

Movement

£'000

 

 

 

 

 

 

 

Cost of sales per proforma Sancus BMS SOCI

(1,037)

(1,144)

9%

107

 

Sancus Loans Limited interest costs

(1,836)

(1,340)

(37%)

(496)

 

Cost of Sales per Sancus BMS SOCI (Note 3)

(2,873)

(2,484)

(16%)

(389)

 

           

 

 

 

Sancus BMS Entity Results (Table 2)

 

£'000

2020 - Half Year

2019 - Half Year

%

 

Offshore

BMS

UK & Ireland

Total

Offshore

BMS

UK & Ireland

Total

 

Proforma Revenue

2,650

517

412

3,579

4,194

807

420

5,421

(34%)

Other Cost of Sales

(56)

-

(15)

(71)

(183)

-

(70)

(253)

(70%)

Operating Expenses

(1,178)

(309)

(805)

(2,292)

(1,267)

(453)

(1,059)

(2,779)

(18%)

Change in ECLs

(163)

-

2

(161)

(565)

(610)

-

(1,175)

(86%)

Debt costs

 

 

 

(966)

 

 

 

(891)

8%

Net Operating Profit/(loss)

1,253

208

(406)

89

2,179

(256)

(709)

323

(72%)

Loan Book £m

150

30

17

197

186

34

2

222

(11%)

On-balance sheet loans £m gross of IFRS 9 (Table 4)

9

8

-

17

15

9

-

24

(29%)

Headcount

12

4

10

26

14

5

11

36

(28%)

 

Revenue

 

Sancus BMS Group revenue on a proforma basis was £3.6m for the first half of the year (H1 2019: £5.4m). On a statutory basis revenue was £5.4m (H1 2019: £6.8m). A reconciliation between the proforma and statutory results is included in Table 1. The reduction in the period is partly due to the run-down of the BMS UK Sarl fund and the impact of Covid-19 which prevented us from closing new deals for the majority of H1 2020. It is hoped that following the relaxation of restrictions we will see this pick up quite substantially in H2 2020 as we have a large pipeline of loans, especially in the UK.

For BMS, which focuses on SME lending, revenue has decreased by 36% compared to the same period last year as a result of the wind down of the UK Sarl fund and consequent reduction in the advisory fee charged to this fund.

The UK and Ireland which we see as our growth potential regions on a combined basis has seen progress slow due to Covid-19 and revenue was flat on last year. There are encouraging signs of this picking up as we move into H2 with Covid-19 restrictions still allowing building sites to remain operational. The UK and Ireland asset backed lending businesses are considered to be our primary focus going forward. The UK office only became fully operational in April 2019 and we are expecting to report an improvement of this revenue stream in the second half of the year, albeit we are concerned that Brexit may have an adverse effect on our expectations. Revenues from interest income on loans relates to the Sancus BMS on-balance sheet loans (Refer Table 4). These have reduced as shown in Table 1 by 71% in the period as on-balance sheet loans have reduced.

Total Cost of Sales

 

Total cost of sales which includes interest and other direct costs has increased in the period from £2.5m in 2019 to £3.0m in 2020. This increase is predominantly through the increased utilization of the HIT Facility (£1.8m in the period to June 2020 vs £1.3m for the comparative period). In addition, finance costs relating to the ZDPs have edged up slightly as the interest rate moved from 5.5% to 8% on their extension to December 2020. Broker costs have decreased due to lack of closed deals in H1 but these are expected to increase again as deals get closed.

 

To measure business unit performance, finance costs are allocated to Sancus BMS to recognise its use of the Group's debt facilities in its lending activities. FinTech Ventures is treated as being funded by equity. This allocation best matches the risk profile of each business unit with its capital structure, as well as recognising that interest costs are effectively serviced by interest income from Sancus BMS.

 

Operating Expenses

 

We continue to manage costs carefully and within the Sancus BMS Group £0.5m of cost savings were achieved in the period with operating expenses for the first 6 months falling from £2.8m to £2.3m. Savings relate predominantly to employment costs. Headcount in the Sancus BMS Group has reduced by 10 heads to 26 at the end of June 2020 from June 2019.

 

 

IFRS 9

 

We have had a movement in expected credit losses (IFRS 9) of £0.2m in the period (June 2019: £1.2m). This movement relates predominantly to interest and fee debtor balances. We did not have any further adjustments to our loan portfolio since 31 December 2019 as those loans that we had concerns around already had provisions made of £2.9m in total. On current analysis these positions have not worsened in total.

 

Other net losses

 

We have reported a £1.8m other net loss in the period (June 2019: £0.8m). Part of this balance (£0.8m) relates to the impairment to the carrying value of net assets down from acquisition value plus accumulated earnings in Sancus IOM Holdings Limited. The Directors have taken a conservative view and decided, in the light of Covid-19 and lack of deals being closed in the first half of 2020, it would seem appropriate to eliminate the implied goodwill. This investment will now be valued going forward at our share of the net assets of Sancus IOM Holdings Limited with no uplift for implied goodwill. Of the remainder £1.0m relates to Sancus Properties Limited whereby in light of Covid-19 we have reduced the holding value of this portfolio.

 

Sancus Properties Limited

 

During the first half of the year we were delighted to have completed the sale of a large block of apartments which was sold for £1.6m cash (net of sale costs) reducing the assets now held in this entity to a large plot of land and a property being developed into three apartments. We have taken the decision as noted above to reduce the value of this portfolio by £1.0m. As at 30 June 2020 these assets had a value assigned to them of £0.9m. We are continuing to explore options to dispose of this portfolio whilst also attempting to ensure the greatest return to shareholders at the same time.

 

Honeycomb Investment Trust (HIT) Facility

 

A special purpose loan vehicle called Sancus Loans Limited ("SLL"), which is non-recourse to GLI, was established during 2018 with a £50m funding capacity. This has been backed by a £45m credit facility from HIT, with a term of 3 years. Sancus has £5m equity invested in this vehicle. Although non-recourse to GLI the SPV is 100% owned by the Group and is therefore consolidated. As a result, both the Sancus Loans Limited loans and HIT facility appear on the consolidated balance sheet but deducted from our proforma results as noted earlier. Revenue within Sancus Loans Limited has increased by £0.7m in the period from £1.6m to £2.3m for the period ended 30 June 2020. This reflects the increased draw down of the facility from £32.6m at the end of June 2019 to £40.8m at the end of June 2020 (maximum facility £45m). At the period end, interest bearing debt comprised:

 

· £41m HIT facility (7.25%) (maximum facility £45m), interest paid monthly.

 

Sancus BMS Proforma Statement of Financial Position (Table 3)

 

£'000

30 June 2020

(unaudited) Note 3

30 June 2020 SLL

30 June 2020

Proforma

31 December 2019 (audited) Note 3

31 December 2019 SLL

31 December 2019

Proforma

Sancus BMS on-Balance Sheet Loans and loan equivalents

14,237

-

14,237

18,347

-

18,347

Sancus Loans Limited loans

41,168

41,168

-

45,885

45,885

-

Goodwill

22,894

-

22,894

22,894

-

22,894

Sancus Properties Limited

902

-

902

3,336

-

3,336

Trade and other receivables

8,222

4,377

3,845

5,627

2,793

2,834

Other assets

2,823

-

2,823

3,761

-

3,761

Cash and cash equivalents

4,933

3,859

1,074

6,568

4,029

2,539

Total Assets

95,179

49,404

45,775

106,418

52,707

53,711

ZDPs payable

(12,604)

-

(12,604)

(16,825)

-

(16,825)

Bond payable

(10,000)

-

(10,000)

(10,000)

-

(10,000)

HIT Debt

(40,748)

(40,748)

-

(44,191)

(44,191)

-

Other Liabilities

(1,763)

(383)

(1,380)

(1,764)

(12)

(1,752)

Total Liabilities

(65,115)

(41,131)

(23,984)

(72,780)

(44,203)

(28,577)

Sancus BMS net assets

30,064

8,273

21,791

33,638

8,504

25,134

Sancus own equity within SLL

-

 

8,273

-

 

8,504

Sancus BMS net assets including SLL equity

 

 

30,064

 

 

33,638

 

Sancus BMS on-Balance Sheet Loans and loan equivalents (Table 4)

 

On-balance sheet loan and loan equivalents have decreased in the period from £18.3m to £14.2m. As previously noted, the disinvestment from SME lending is allowing asset utilisation to improve, which will drive an improvement in ROTA and shareholder value over time. As we have also seen from our loan book funding, our access to capital has also improved allowing funding of asset backed secured loans from other sources such as the HIT facility, SLNs and Co-Funders.

 

Post period end the BMS loan book has reduced by a further £0.7m following the successful refinancing of one of the loans within the fund and cash returned to note holders.

 

£'000

30 June 2020

31 December 2019

Jersey

6,024

8,434

Gibraltar

1,722

3,274

Guernsey

1,067

1,074

BMS - Investment in the fund and other loans

8,161

8,273

Sancus UK

32

60

Ireland

99

100

IFRS 9 Provision

(2,868)

(2,868)

Total Sancus BMS on-Balance Sheet Loans and loan equivalents (ex SLL)

14,237

18,347

 

 

Marketing

 

Although Covid-19 has put the brakes on growth for H1 2020 the Sancus brand is becoming increasingly well-known and we are receiving a healthy flow of new lending opportunities with strong growth in new Co-Funders.

 

Loan Book

 

We have seen a reduction in the loan book of 11% since last June from £222m to £197m. This is a function of the offshore loan book seeing a large repayment of loans in the period but only £22m loan deployments in the first six months of the year due to Covid-19. During Covid-19, the completion of new loans slowed as on-site visits were hampered by lockdown. Now we are getting back to some normality, especially in the offshore regions, we except to see the loan book increase again.

 

Our on-balance sheet loans have decreased by 32% from 30 June 2019 with the continued focus on improving ROTA.

 

Loan deployment for asset backed lending is a key metric we use to monitor the performance of the Sancus BMS Group. Over the last three years we have seen a steady increase in loan deployments from £102m for the full year 2017, £115m for the full year 2018 and £123m in 2019. For the first six months of 2020 loan deployments were 70% behind the same period last year at £22m (H1 2019: £73m). We have set ourselves stretching targets for this year incorporating the new asset backed lending for the UK and Ireland. Although we have not been able to reach the targets we set for ourselves in H1, we are hoping to narrow the short fall in H2 with a strong backlog of loans coming through the pipeline.

 

Sancus Loan Notes

 

The Sancus Loan Notes ("SLNs") comprise a planned series of Special Purpose Vehicles ("SPVs") designed to act like securitisation vehicles to help diversify our funding options and enable additional Co-Funder participation in diversified loan portfolios. These are attractive to new clients that want to participate in a pooled vehicle, delivered across a number of loans, rather than via direct participation in individual loans. SLN5 had a successful launch in November 2018, and has now grown to £19.6m. This matures on 8 November 2021 and has a coupon of 7%. Following that SLN6 had a successful launch in December 2019 with a coupon of 8%. This note currently stands at £4.4m and matures on 30 November 2021. As part of the structure of the loan notes, Sancus BMS has provided a 10% first loss position on SLN5. On SLN6 Sancus BMS has not provided a first loss position. Following the successful demand of this product, Amberton Asset Management are looking into launching SLN7 on maturity of SLN5 and SLN6.

 

Technology

 

The Group continues to invest in its technology. Following the successful launch of the Group's proprietary Loan Management System (LMS) in 2017, an online reporting platform for offshore Co-Funders which was rolled out in 2018. We have now rolled out a fully online transactional platform in the UK.

 

Sancus BMS Group KPIs

 

We set out in our 2018 Annual Report that we will be reporting our KPIs going forward to demonstrate the progress we are making over time. We are committed to driving shareholder value through judicious growth, improving asset utilisation and cost controls. We believe the share price will positively reflect improvement in these metrics over time (Refer to Note 20 Performance Measures).

 

The Directors consider the following financial indicators as KPIs:

· Lending - loan deployment and loan book growth;

· Return on tangible assets (ROTA); and

· Profitability.

 

The table below gives a breakdown of Sancus BMS KPIs. This also includes those items not considered KPI's, but which give a better understanding of the figures.

 

Sancus BMS - KPIs (Table 5)

June

 2020

June

 2019

% Change

December 2019

% Change

December 2018

BMS managed loan book

£30m

£34m

(12%)

£33m

(8%)

£40m

Sancus asset backed lending book

£167m

£188m

(11%)

£199m

(16%)

£168m

Total Sancus BMS Loan Book

£197m

£222m

(11%)

£232m

(15%)

£208m

Loan Deployments

£22m

£73m

(70%)

£123m

N/A

£115m

Return on Tangible Assets

0.5%

1.4%

(64%)

0.9%

(44%)

(0.4%)

Net operating profit/(loss)

£0.1m

£0.3m

(72%)

£0.4m

N/A

(£0.2m)

Cost Income Ratio

98%

94%

4%

96%

2%

102%

On balance sheet loans before IFRS9

£17.1m

£23.7m

(28%)

£21.2m

(19%)

£26.0m

Revenue (proforma)

£3.6m

£5.4m

(34%)

£9.6m

N/A

£11.7m

Operating expenses

£2.3m

£2.8m

(18%)

£5.5m

N/A

£6.4m

Gross Profit

£2.5m

£4.3m

(41%)

£7.5m

N/A

£9.3m

Cost of borrowing

£1.0m

£0.9m

8%

£1.7m

N/A

£1.8m

 

 

Lending - loan deployment and loan book growth

 

Sancus asset backed lending has decreased by 16% since last December 2019 when it was £199m to £167m at 30 June 2020. Although we have seen a decline, this hides a positive message that over £50m of Co-Funder money was returned during the period as the lending team worked tirelessly to ensure loans competed as planned. As we have seen the new loans deployed decline in the period due to Covid-19 this is not unexpected. We are positive that as new loan opportunities arise the loan book will increase as Co-Funders are attracted to the risk adjusted returns, especially when compared to the all-time low alternative yielding assets such as cash or bonds.

 

As previously mentioned, the BMS loan book is in runoff and we will utilise the cash coming back into the business for the repayment of the ZDPs on 5 December 2020.

 

Loan deployments in 2020 to 30 June 2020 was only £22m as we saw the impact of Covid-19. Loan deployments are classified as new loans written in the year and a key target for the sales teams to focus on.

 

Return on Total Assets ("ROTA") (Refer Note 20 for performance measure calculations)

 

Due to the effects of Covid-19 we are unable to report an improvement in this ratio in the first half of the year, it having declined to 0.5% from 0.9% at the 2019 year-end. As Covid-19 restrictions are eased and the world gets back to some sense of normality we expect to see progress made on this ratio going forwards.

 

 

Cost Income Ratio ("CIR") (Refer Note 20 for performance measure calculations)

 

The total costs include operating expenses, debt costs, broker costs and IFRS9 adjustments as set out in Note 20. CIR for the first half of 2020 has increased to 98% from 96% for the full year 2019. Whilst cost efficiencies have been delivered across a number of areas the lack of revenue has nullified this benefit. As Covid-19 restrictions are eased and the world gets back to some sense of normality we expect to see progress made on this ratio going forwards.

 

FinTech Ventures

 

The total fair value at 30 June 2020 of £2.2m (31 December 2019: £6.3m) is made up of investments mainly in debt in the form of convertible loan notes where we retain the potential upside from being able to convert on favourable terms should the platforms deliver a successful opportunity for us to exit. Given the difficult market conditions, some further tough decisions have been made to write down the portfolio which has resulted in a net movement of £4.2m during the period.

 

At the time that these minority stakes in the various platforms were acquired by the Group back in 2014 and 2015, it was expected that they would achieve profitability far quicker than they have. In practice, the plethora of FinTech start-ups has created a very competitive market and scale has been harder to achieve. As a portfolio of early stage businesses, it is perhaps inevitable that some platforms have either failed or have underperformed to the point where it has been appropriate to take write-downs. Whilst investment risk related to this portfolio will remain an ongoing feature, we hope that there is potential to secure enhanced valuations from those platforms which are continuing to operate.

 

The valuation methodology employed by the Group is unchanged and remains compliant with IFRS 13, based on a fair value approach and taking into account the International Private Equity and Venture Capital Valuation Guidelines ("IPEV"), which provides guidance on fair value valuation practices.

 

For commercial reasons we do not disclose the carrying value of each platform.

 

STRATEGIC PLAN

Strategic Objectives

The Group's strategy is to maximise shareholder value through growing the profitability of Sancus BMS and realising value from its investments in FinTech Ventures. We are focused on the main key targets below, and our aim is to improve the performance of these KPIs gradually overtime.  

· Become a capital efficient business

· Focus on creating shareholder value

· Profitably expand the funding base

· Realise value from FinTech Ventures Investments

 

Become a capital light entity

 

We have been focussed on reducing our on-balance sheet loan book exposure and deploying these funds into acquiring and repaying the ZDPs. This in turn will de-risk our balance sheet and improve the Return of Tangible Assets ("ROTA") (Refer Note 20 for Performance Measures calculations). At the end of June 2020 ROTA for Sancus BMS was 0.5% (31 December 2019: 0.9%).

 

Sancus needs capital to underwrite its deal flow but continual efforts to diversify and grow our Co-Funders improves our ability to syndicate and drive better returns on the Group's assets.

 

Focus on creating shareholder value

 

We believe value creation will be achieved by:

 

· Revenue growth - this is largely driven by loan deployment.

· Improving our ROTA - by reducing our on-balance sheet loan book and increasing operating profits.

· Increasing operating profits - by increasing gross margin and reducing costs.

 

Over time we expect the UK and Ireland to be our largest revenue generating entities and as noted our focus is on growing these offices. The UK office was opened in London in April 2019 (after closing the larger Basingstoke office). Whilst revenue in the UK has been modest to date, the pipeline is healthy, and we expect revenue to pick up in the second half. The position is similar in Ireland. The UK business also benefits from our own proprietary fully transactional electronic platform. These are the largest potential markets and are key for growth.

 

We have seen a decrease in Sancus BMS Group ROTA from 0.9% in 2019 to 0.5% at 30 June 2020.

 

2019 saw a reorganization within the Group. Since then we have reduced headcount across the Group by a further 5 in the first half of 2020, resulting in an improved cost income ratio.

 

Profitably expand the funding base

 

Growing and diversifying pools of lending capital is critical for our growth. Our funding sources include institutional, corporate and high net worth individuals. We continue to launch further loan notes through Amberton Asset Management or similar structured vehicles to expand our Co-Funder base. We also continue to target the Co-Funder base and nurture relationships. The HIT funding line is designed to be complementary to our Co-Funder base and work alongside it to complete on larger sized loans which have a greater revenue impact on the Group. Following some large loan repayments in the period our total syndicated lending has decreased by 11% in the last twelve months from £188m at 31 June 2019 to £167m at 30 June 2020. The co-funder ratio however has increased up to 95% from 92% a year ago as we reduce our on balance sheet exposure.

 

We also continue to explore long term financing lines that sit alongside our syndicated lending approach.

 

Realise value from FinTech Ventures Investments

 

We continue to assist platforms with strategy, corporate finance and capital restructuring within the FinTech Ventures portfolio. Monitoring and governance of FinTech Ventures continues. It remains a challenging market for many of the FinTech platforms to raise further capital, which in several cases is impacting their growth. Sadly, the outcome is binary in that they will either succeed or be forced into administration.

 

 

 

 

Outlook

 

Last year was a year of reorganisation as we built out the Sancus BMS entities and focused on the core business, which is capable of creating significant value for shareholders. Our target was to deleverage our balance sheet and become a capital efficient business, which in turn will enable us to start paying dividends again. Management remains focused on these objectives, which it expects to translate into improved profitability and ROTA over time. Covid-19 has negatively affected our results for the first half of the year, but we do see a lot of opportunities for alternative lenders such as ourselves and expect to see improvements in the second half of this year.

 

Finally, I want to thank all shareholders for their continued support during this period of change. I fully acknowledge that the journey to date has been disappointing. However, we have successfully aligned the business to focus on Sancus, which through its multi-jurisdictional asset backed secured lending service, is in a strong position to deliver future growth, profitability and in due course recommence the dividend programme.

 

Please keep safe and look after your loved ones.

 

Andrew Whelan

Chief Executive Officer

30 September 2020

 

 

 

 

RISKS, UNCERTAINTIES AND RESPONSIBILITY STATEMENT

 

Risks and uncertainties

 

There are a number of potential risks and uncertainties which could have a material impact on the group's performance over the remainder of the financial year. These include, but are not limited to, Capital and liquidity risk, Regulatory and compliance risk, Market risk, Credit risk with respect to the loan book (primarily bridging loans and, increasingly, development loans), Operational risk - execution of Sancus BMS strategy and Investment risk - platform valuations. These risks along with the risks arising from Covid-19, remain unchanged from December 2019 and are not expected to change in the 6 months to the end of the financial year. Further details on these risks and uncertainties can be found in the December 2019 Annual Report.

 

 

Responsibility statement

 

The Directors confirm that to the best of their knowledge:

 

§ The Interim Report has been prepared in accordance with the AIM rules of the London Stock Exchange;

 

§ This financial information has been prepared in accordance with IAS 34 as adopted by the EU;

 

§ The interim results include a fair review of the important events during the first half of the financial year and their impact on the financial information as required by DTR 4.2.7R; and

 

§ The interim results include a fair review of the disclosure of related party transactions as required by DTR 4.2.8R.

 

 

 

Approved and signed on behalf of the Board of Directors

30 September 2020

 

 

 

 

 

 

 

 

INDEPENDENT REVIEW REPORT TO GLI FINANCE LIMITED

 

We have been engaged by the Company to review the condensed set of Consolidated Financial Statements in the Interim Report for the six months ended 30 June 2020 which comprises the Condensed Consolidated Statement of Comprehensive Income, the Condensed Consolidated Statement of Financial Position, the Condensed Consolidated Statement of Changes in Shareholders' Equity, the Condensed Consolidated Statement of Cash Flows and related Notes 1 to 20. We have read the other information contained in the Interim Report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of Consolidated Financial Statements.

 

This report is made solely to the Company in accordance with International Standard on Review Engagements (UK & Ireland) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Auditing Practices Board. Our work has been undertaken so that we might state to the company those matters we are required to state to it in an independent review report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company, for our review work, for this report, or for the conclusions we have formed.

 

Directors' responsibilities

 

The Interim Report is the responsibility of, and has been approved by, the Directors. The Directors are responsible for preparing the Interim Report in accordance with the AIM Rules of the London Stock Exchange.

 

As disclosed in Note 2, the annual financial statements of the Group are prepared in accordance with IFRSs as adopted by the European Union. The condensed set of Financial Statements included in this Interim Report has been prepared in accordance with International Accounting Standard 34 "Interim Financial Reporting," as adopted by the European Union.

 

Our responsibility

 

Our responsibility is to express to the Company a conclusion on the condensed set of Financial Statements in the Interim Report based on our review.

 

Scope of review

 

We conducted our review in accordance with International Standard on Review Engagements (UK & Ireland) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

 

Conclusion

 

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of Financial Statements in the Interim Report for the six months ended 30 June 2020 is not prepared, in all material respects, in accordance with International Accounting Standard 34 as adopted by the European Union and the AIM Rules of the London Stock Exchange.

 

Material uncertainty relating to going concern

 

We draw attention to Note 2(c) in the financial statements, which indicates that there is a material uncertainty over the timing and quantum of cash flows needed to generate sufficient cash reserves to extinguish its liabilities as they fall due. The mitigations identified by the Directors are inherently uncertain as to their success.

 

As stated in Note 2(c), these events or conditions indicate that a material uncertainty exists that may cast significant doubt on the Group's and the Company's ability to continue as a going concern. Our conclusion is not modified in respect of this matter.

 

 

 

 

 

 

Deloitte LLP

Guernsey, Channel Islands

30 September 2020

 

 

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Unaudited)

 

 

 

Notes

Period ended

Period ended

 

 

30 June 2020

(unaudited)

 

£'000

30 June 2019

(unaudited)

 

£'000

 

 

 

 

Revenue

 

4

5,498

7,086

Cost of sales

 

5

(3,011)

(2,488)

Gross profit

 

2,487

4,598

Operating expenses

6

(2,824)

(3,565)

Changes in expected credit losses

18

(161)

(1,175)

Operating loss

 

(498)

(142)

FinTech Ventures fair value movement

18

(4,238)

(5,190)

FinTech Ventures foreign exchange gain

 

64

39

Other net losses

7

(1,776)

(699)

Loss for the period before tax

 

(6,448)

(5,992)

Income tax expense

 

(67)

(144)

Loss for the period after tax

 

(6,515)

(6,136)

 

 

 

 

Items that may be reclassified subsequently to profit and loss

 

 

 

Foreign exchange arising on consolidation

 

(26)

(5)

Other comprehensive losses for the period after tax

 

(26)

(5)

Total comprehensive loss for the period

 

(6,541)

(6,141)

 

 

 

 

 

 

 

 

 

Basic and Diluted loss per Ordinary Share

8

(2.14)p

(2.02)p

 

 

 

 

 

 

 

 

 

The accompanying Notes form an integral part of these financial statements.

 

 

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION (Unaudited)

 

 

 

 

 

30 June 2020

(unaudited)

31 December 2019 (audited)

ASSETS

Notes

£'000

£'000

Non-current assets

 

 

 

Fixed assets

9

887

1,018

Goodwill

10

22,894

22,894

Other intangible assets

11

251

334

Sancus BMS loans and loan equivalents

18

3,982

8,950

FinTech Ventures investments

18

2,164

6,299

Investments in joint ventures and associates

 

1,948

2,703

Total Non-current assets

 

32,126

42,198

 

 

 

 

Current assets

 

 

 

Loans through platforms

 

21

31

Other assets

13

902

3,336

Sancus BMS loans and loan equivalents

18

51,423

55,282

Trade and other receivables

12

8,588

5,909

Cash and cash equivalents

 

6,621

7,244

Total current assets

 

67,555

71,802

 

 

 

 

Total assets

 

99,681

114,000

 

 

 

 

EQUITY

 

 

 

Share premium

14

112,557

112,557

Treasury shares

14

(1,099)

(1,099)

Retained earnings

 

(77,626)

(71,085)

Total Equity

 

33,832

40,373

 

 

 

 

LIABILITIES

 

 

 

Non-current liabilities

15

576

54,870

Current liabilities

15

65,273

18,757

Total liabilities

 

65,849

73,627

 

 

 

 

Total equity and liabilities

 

99,681

114,000

 

 

 

The financial statements were approved by the Board of Directors on 30 September 2020 and were signed on its behalf by:

 

 

Director: Patrick Firth

Director: John Whittle

 

 

 

 

 

 

The accompanying Notes form an integral part of these financial statements.

 

 

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)

 

 

 

 

 

 

Share

 Premium

Treasury Shares

Foreign Exchange Reserve

Retained Earnings/

(Losses)

Total Equity

 

 

 

 

£'000

£'000

£'000

£'000

£'000

Balance at 31 December 2019 (audited)

 

 

112,557

(1,099)

22

(71,107)

40,373

Transactions with owners

 

 

 

-

-

-

-

-

Total comprehensive loss for the period

 

 

-

-

(26)

(6,515)

(6,541)

Balance at 30 June 2020 (unaudited)

 

 

 

112,557

(1,099)

(4)

(77,622)

33,832

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 31 December 2018 (audited)

 

112,557

(1,162)

1

(61,169)

50,227

Adjustment on adoption of IFRS 16

 

 

-

-

-

(18)

(18)

Restated balance at 1 January 2019

 

 

112,557

(1,162)

1

(61,187)

50,209

Transferred from management

 

 

-

(336)

-

-

(336)

Bonuses settled by shares

 

 

-

399

-

(170)

229

Transactions with owners

 

 

 

-

63

-

(170)

(107)

Total comprehensive loss for the period

 

 

-

-

(5)

(6,136)

(6,141)

Balance at 30 June 2019 (unaudited)

 

 

 

112,557

(1,099)

(4)

(67,493)

43,961

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes form an integral part of these financial statements.

 

 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)

 

 

 

Period ended

Period ended

 

 

30 June 2020

(unaudited)

30 June 2019

(unaudited)

 

Notes

£'000

£'000

 

Cash outflow from operations, excluding loan movements

 

16

 

(2,823)

 

(1,860)

Decrease / (Increase) in Sancus BMS loans

 

3,168

(1,182)

Decrease in loans through platforms

 

10

13

Decrease in loans to UK and Irish SARLS

 

113

1,515

Decrease / (Increase) in loans through the HIT facility

 

5,084

(8,242)

Repayment of Sancus Loan notes

 

-

3,311

Net cash inflow / (outflow) from operating activities

 

5,552

(6,445)

 

Cash inflows / (outflows) from investing activities

 

 

 

Disposal of IOM Preference Shares

 

-

950

Repayments / (Investments) in FinTech Ventures

 

(49)

70

Divestment in UK and Irish SARLS

 

-

82

Expenditure on SPL Properties

13

(147)

(708)

Sale of SPL Properties

13

1,598

435

Expenditure on fixed assets and intangibles

 

(8)

(172)

Net cash inflow from investing activities

 

1,394

657

 

 

 

 

Cash inflows / (outflows) from financing activities

 

 

 

(Repayment) / Draw down of HIT facility

16

(3,499)

9,706

Purchase of own shares

 

-

(336)

Capital element of lease payments

16

(128)

(94)

Repayment of ZDPs

16

(3,942)

(4,290)

Net cash (outflow) / inflow from financing activities

 

(7,569)

4,986

 

 

 

 

Net decrease in cash and cash equivalents

 

(623)

(802)

 

 

 

 

Cash and cash equivalents at beginning of period

 

7,244

5,863

 

 

 

 

Cash and cash equivalents at end of period

 

6,621

5,061

 

 

£3,859,000 of the £6,621,000 cash held at 30 June 2020 is for the exclusive use of Sancus Loans Limited (June 2019: £2,172,000 of the £5,061,000).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying Notes form an integral part of these financial statements.

 

 

NOTES TO THE CONDENSED INTERIM FINANCIAL STATEMENTS

 

1. GENERAL INFORMATION

 

GLI Finance Limited (the "Company"), and together with its subsidiaries, ("the Group") was incorporated, and domiciled in Guernsey, Channel Islands, as a company limited by shares and with limited liability, on 9 June 2005 in accordance with The Companies (Guernsey) Law, 1994 (since superseded by The Companies (Guernsey) Law, 2008). Until 25 March 2015, the Company was an Authorised Closed-ended Investment Scheme and was subject to the Authorised Closed-ended Investment Scheme Rules 2008 issued by the Guernsey Financial Services Commission ("GFSC"). On 25 March 2015, the Company was registered with the GFSC as a Non-Regulated Financial Services Business, at which point the Company's authorised fund status was revoked. The Company's Ordinary Shares were admitted to trading on the AIM market of the London Stock Exchange on 5 August 2005 and its issued zero dividend preference shares were listed and traded on the Standard listing Segment of the main market of the London Stock Exchange with effect from 5 October 2015.

 

The Company does not have a fixed life and the Articles do not contain any trigger events for a voluntary liquidation of the Company.

 

The Company is an operating company for the purpose of the AIM rules. The Executive Team is responsible for the management of the Company.

 

As at 30 June 2020, the Group comprises the Company and its subsidiaries.

 

The Company has taken advantage of the exemption conferred by the Companies (Guernsey) Law, 2008, Section 244, not to prepare company only financial statements which is consistent with the 2019 Annual Report.

 

2. ACCOUNTING POLICIES

 

(a) Basis of preparation

 

These condensed consolidated financial statements ("financial statements") have been prepared in accordance with International Financial Reporting Standard (IAS) 34 'Interim Financial Reporting', as adopted by the European Union and all applicable requirements of Guernsey Company Law. They do not include all the information and disclosures required in annual financial statements and should be read in conjunction with the Company's annual audited financial statements for the year ended 31 December 2019, which have been prepared in accordance with International Financial Reporting Standards ("IFRS") as endorsed by the European Union.

 

The Group does not operate in an industry where significant or cyclical variations, as a result of seasonal activity, are experienced during any particular financial period.

 

These financial statements were authorised for issue by the Company Directors on 30 September 2020.

 

(b) Principal accounting policies

 

The same accounting policies and methods of computation are followed in these financial statements as in the last annual financial statements for the year ended 31 December 2019.

 

(c) Going Concern

 

The Directors have considered the going concern basis in the preparation of the financial statements as supported by the Director's assessment of the Company's and Group's ability to pay its debts as they fall due and have assessed the current position and the principal risks facing the business with a view to assessing the prospects of the Company.

 

The assessment has been supported by subjecting the Group's financial forecasts over a period of at least twelve months from the end of the reporting date to severe but reasonable scenarios and reviewing the effectiveness of any mitigating actions.

The Company has certain liabilities that fall due in the next 12 months which are noted below:

· the final capital entitlement of the Company's ZDP shares is £13.1m, which is repayable on 5 December 2020;

· the facility with Honeycomb Investment Trust plc ("HIT"), which as at 30 June 2020 was £40.8m drawn, expires on 28 January 2021; and

· the £10m bond is repayable on 30 June 2021 (the "GLI Bonds").

 

Based on current cash reserves plus the loan maturity profiles of the Sancus and BMS Fund loan books, our cash flow forecasts indicate there would be sufficient cash available to continue on a Going Concern basis. However, as we have seen in the past, timings of the repayment of loans can vary and deviate from expectations as development loans may run over and in the case of the BMS Fund, the refinance of some of the loans may not occur as planned. In the past year especially, we have seen this occur with the impact of Brexit playing some part, but this risk is now heightened by Covid-19.

 

Based on the Company's liabilities and taking into account the various possible outcomes and assumptions as part of the Going Concern model, they constitute a material uncertainty that may cast significant doubt over the Company's and Group's ability to continue as a Going Concern, such that it may be unable to realise its assets and discharge its liabilities in the normal course of business.

 

The Company has been considering its options regarding these liabilities, which include their repayment and/or extension, and is considering:

 

· an equity fundraising of up to £2.5m at 2.5p which represents a premium of 11% to the Company's closing mid-market share price on 29 September 2020, £1.5m of which would be underwritten by Somerston FinTech Limited ("Somerston"), and which would also be supported by Philip J Milton & Company Plc, both major shareholders in the Company; and

· the issue of up to £15m of new corporate bonds, with a coupon of 7% and a maturity date in 2026 of which Somerston would subscribe for £6m (together, the "Proposed Fundraising"). Subscribers of the new bonds would be issued with warrants over ordinary shares at an exercise price of 2.5p, representing 0.25% of the Company's ordinary shares for each £100,000 subscribed.

 

Somerston's participation in the Proposed Fundraising would be subject to due diligence.

 

The proceeds of the Proposed Fundraising would be used to repay the GLI Bonds and the Company expects that it would use its own cash resources to fund any shortfall. In conjunction with the Proposed Fundraising, the Company intends to seek a two-year extension to the repayment date of the Company's ZDP shares on terms to be agreed and we are engaged with HIT regarding the extension and increase of the HIT facility.

 

The Proposed Fundraising together with the proposals outlined above are subject to further consideration by the Board, consultation with the relevant stakeholders, including ordinary shareholders, ZDP shareholders, bondholders and HIT and, if pursued, relevant shareholder and regulatory approvals and consents. Accordingly, there can be no certainty that the Proposed Fundraising or the other proposals will proceed.

 

The Board further notes that management have undertaken a detailed review of the loan books and stress tested for the impact of a second phase of Covid-19. Based on this review and on current available information, the results are very similar to the conclusions made in the 2019 Annual Report in that it is likely to impact the timing of receipt of the outstanding loan book in the short to medium term, but not the ultimate recoverability of the loans as these are largely asset backed with an average LTV of 59%. At this stage however we cannot forecast with certainly the full impact a second wave of Covid-19 will have on the timings of the loan repayments or whether there is a more severe deterioration in the markets for the underlying security which would impact recoverability. As part of the stress testing, the assumptions we have made regarding the operational performance (income and expenditure) driven by loan book growth, remains unchanged and that even under the more conservative scenarios the Group is forecast to generate sufficient income to meet expenses.

There are sensitivities around the various assumptions described above which have been stress tested for delays and other risks that the loans may not repay on time, that the unfunded commitments may not all be funded by Co-Funders and that the real estate asset sales may not occur as planned in 2020/21.

All of these factors and assumptions combined constitute a material uncertainty that may cast significant doubt over the Company's ability to continue as a going concern, such that it may be unable to realise its assets and discharge its liabilities in the normal course of business. The Directors expect that if they are able to action the mitigations in accordance with the plan outlined above, the material uncertainty will be extinguished. The Directors are therefore of the opinion that the Company will have adequate financial resources to continue in operation and meet its liabilities as they fall due for the foreseeable future and continue to adopt the going concern basis in preparing the financial statements.

(d) Critical accounting estimates and judgements in applying accounting policies

 

The critical accounting estimates and judgements are as outlined in the financial statements for the year ended 31 December 2019.

 

3. SEGMENTAL REPORTING

 

Operating segments are reported in a manner consistent with the manner in which the Executive Team reports to the Board, which is regarded to be the Chief Operating Decision Maker (CODM) as defined under IFRS 8. The Executive Team is responsible for allocating resources and assessing performance of the Group, as well as making strategic investment decisions, subject to the oversight of the Board of Directors. The Executive Team is responsible for the entire Group and considers it to have two operating segments as well as group treasury.

The segments are as follows:

 

(1) Sancus BMS which consists of Platforms with an established business model, Amberton (which fundraises for Sancus BMS) and Investments in the BMS UK fund;

 

(2) FinTech Ventures which holds eight platform investments (31 December 2019: nine); and

 

(3) Group Treasury which primarily includes cash balances and related expenses to manage the Group's consolidated position and listed holding company.

 

The accounting policies of each segment are the same as the accounting policies of the Group, therefore no differences arise between the segment report and the Group statements.

 

 

 

 

 

 

 

 

 

 

 

30 June 2020

30 June 2019

£'000

Sancus BMS

FinTech Ventures

Group Treasury

Total Group

Sancus BMS

FinTech Ventures

Group Treasury

Total Group

 

 

 

 

 

 

 

 

 

 

Revenue

5,415

83

-

5,498

6,761

325

-

7,086

Cost of sales

(2,873)

-

(138)

(3,011)

(2,484)

-

(4)

(2,488)

Gross profit / (loss)

2,542

83

(138)

2,487

4,277

325

(4)

4,598

Operating expenses

(2,292)

(167)

(365)

(2,824)

(2,779)

(234)

(552)

(3,565)

Changes in expected credit losses

(161)

-

-

(161)

(1,175)

-

-

(1,175)

Operating profit / (loss)

89

(84)

(503)

(498)

323

91

(556)

(142)

FinTech Ventures fair value movement

-

(4,238)

-

(4,238)

-

(5,190)

-

(5,190)

FinTech Ventures foreign exchange gain

-

64

-

64

-

39

-

39

Other net (losses) / gains

(1,776)

-

-

(1,776)

(753)

54

-

(699)

Loss for the period before tax

(1,687)

(4,258)

(503)

(6,448)

(430)

(5,006)

(556)

(5,992)

Income tax expense

(67)

-

-

(67)

(144)

-

-

(144)

Loss for the period after tax

(1,754)

(4,258)

(503)

(6,515)

(574)

(5,006)

(556)

(6,136)

 

 

 

 

 

 

 

 

 

Other comprehensive losses

 

 

 

 

 

 

 

 

Foreign exchange on consolidation

(26)

-

-

(26)

(5)

-

-

(5)

Total comprehensive loss for the period

(1,780)

(4,258)

(503)

(6,541)

(579)

(5,006)

(556)

(6,141)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

30 June 2020

31 December 2019

£'000

Sancus BMS

FinTech Ventures

Group Treasury

Total

 Group

Sancus BMS

FinTech Ventures

Group Treasury

Total Group

 

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

Non-current assets

 

 

 

 

 

 

 

 

Fixed assets

603

 -

284

887

694

 -

 324

1,018

Goodwill

22,894

 -

 -

22,894

 22,894

 -

 -

 22,894

Other intangible assets

251

-

-

251

334

-

-

334

Sancus BMS loans and loan equivalents

3,982

-

-

3,982

8,950

-

-

8,950

FinTech Ventures investments

 -

2,164

 -

2,164

 -

6,299

 -

6,299

Joint ventures and associates

1,948

 -

 -

1,948

2,703

 -

 -

2,703

Total Non-current assets

29,678

2,164

284

32,126

35,575

6,299

324

42,198

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

Loans through platforms

21

-

 -

21

30

1

 -

31

Other assets

902

-

-

902

3,336

-

-

3,336

Sancus BMS loans and loan equivalents

51,423

-

-

51,423

55,282

-

-

55,282

Trade and other receivables

8,222

286

80

8,588

5,627

282

-

5,909

Cash and cash equivalents

4,933

22

1,666

6,621

6,568

19

657

7,244

Total current assets

65,501

308

1,746

67,555

70,843

302

657

71,802

 

 

 

 

 

 

 

 

 

Total assets

95,179

2,472

2,030

99,681

106,418

6,601

981

114,000

 

 

 

 

 

 

 

 

 

LIABILITIES

 

 

 

 

 

 

 

 

Non-current liabilities

450

-

126

576

54,708

-

162

54,870

Current liabilities

64,665

-

608

65,273

18,072

12

673

18,757

Total liabilities

65,115

-

734

65,849

72,780

12

835

73,627

 

 

 

 

 

 

 

 

 

Net Assets

30,064

2,472

1,296

33,832

33,638

6,589

146

40,373

 

 

 

Sancus BMS is treated as being funded by the debt facilities whilst FinTech Ventures is treated as being funded by equity. This allocation best matches the risk profile of each business unit with its capital structure, as well as recognising that interest costs are effectively serviced by interest and fee income from Sancus BMS.

 

 

 

4. REVENUE

 

 

30 June 2020

(unaudited)

30 June 2019

(unaudited)

 

£'000

£'000

Co-Funder fees

890

965

Earn out (exit) fees

926

561

Advisory fees

230

325

Transaction fees

563

1,227

Total revenue from contracts with customers

2,609

3,078

 

 

 

Interest on loans

556

1,945

HIT interest income

2,280

1,611

Other income

53

452

Total Revenue

5,498

7,086

 

 

5. COST OF SALES

 

 

30 June 2020

(unaudited)

30 June 2019

(unaudited)

 

£'000

£'000

Interest costs

1,104

895

HIT interest costs

1,836

1,340

Other cost of sales

71

253

Total cost of sales

3,011

2,488

 

 

6. OPERATING EXPENSES

 

 

30 June 2020

(unaudited)

30 June 2019

(unaudited)

 

£'000

£'000

 

 

 

Administration and secretarial fees

25

63

Amortisation and depreciation

216

263

Audit fees

111

107

Corporate Insurance

42

28

Directors Remuneration

64

49

Employment costs

1,647

2,260

Investor relations expenses

36

44

Legal and professional fees

114

106

Marketing expenses

19

22

NOMAD fees

38

38

Other office and administration costs

348

404

Pension costs

141

155

Registrar fees

15

17

Sundry

8

9

Total operating expenses

2,824

3,565

 

 

7. OTHER NET LOSSES

 

Of the £1,776,000 Other net losses £763,000 relates to the write down of the investment in Sancus IOM Holdings Limited. The Directors have taken a conservative view and decided, in light of Covid-19 and lack of deals being closed in this entity in the first half of 2020, that it would seem appropriate to write down this investment. This investment will be valued on share of Net Assets going forward. Of the remainder, £983,000 relates to the write down of other assets (see note 13).

 

 

8. LOSS PER ORDINARY SHARE

 

Consolidated loss per Ordinary Share has been calculated by dividing the consolidated loss attributable to Ordinary Shareholders in the period by the weighted average number of Ordinary Shares outstanding (excluding treasury shares) during the period. There was no dilutive effect for potential Ordinary Shares during the current or prior periods.

 

 

 

30 June 2020

(unaudited)

30 June 2019

(unaudited)

 

 

 

Number of shares in issue

312,065,699

312,065,699

Weighted average number of shares outstanding (excluding treasury shares)

304,139,700

304,520,121

Consolidated loss attributable to Ordinary Shareholders in the period

£6,515,000

£6,136,000

Consolidated Loss per Ordinary Share

(2.14)p

(2.02)p

 

 

 

 

 

9. FIXED ASSETS

 

 

Right of use assets

Property & Equipment

Total

Cost

£'000

£'000

£'000

At 31 December 2019

1,089

433

1,522

Additions in the period

-

8

8

Lease adjustment

262

-

262

Expired lease

(75)

-

(75)

At 30 June 2020

1,276

441

1,717

 

Accumulated depreciation

£'000

£'000

£'000

At 31 December 2019

231

273

504

Lease adjustment

268

-

268

Charge in the period

107

26

133

Expired lease

(75)

-

(75)

At 30 June 2020

531

299

830

 

 

 

 

Net book value 30 June 2020

745

142

887

 

 

 

 

Net book value 31 December 2019

858

160

1,018

 

 

 

 

 

 

10. GOODWILL

 

 

Goodwill at 30 June 2020 and 31 December 2019 comprises:

 

 

 

 

£'000

 

 

 

Sancus Jersey

 

14,255

Sancus Gibraltar

 

8,639

Total

 

22,894

 

 

 

Impairment tests

 

The carrying amount of goodwill arising on the acquisition of certain subsidiaries is assessed by the Board for impairment on an annual basis or sooner if there has been any indication of impairment. The Covid-19 pandemic is considered to be an indicative event of impairment. As a result, the Board have carried out a full impairment review of the carrying amount of goodwill. The value in use of Sancus Jersey and Sancus Gibraltar was based on an internal Discounted Cash Flow ("DCF") value in use analysis using cash flow forecasts for the years 2020/21 to 2024/25. The starting point for each of the cash flows was the revised forecast for 2020 produced by Sancus Jersey and Gibraltar management. Management's revenue forecasts applied a compound annual growth rate (CAGR) to revenue of 7.3% and 8.4% for Jersey and Gibraltar respectively. A cost of equity discount rate of 12.8% was employed in the valuation model for Sancus Jersey and 13.3% for Sancus Gibraltar. The resultant valuation indicated that no impairment of goodwill was required in either Sancus Jersey or Sancus Gibraltar, with significant headroom.

 

Goodwill valuation sensitivities

 

When the discounted cash flow valuation methodology is utilised as the primary goodwill impairment test, the variables which influence the results most significantly are the discount rates applied to the future cash flows and the revenue forecasts. The table below shows the impact on the Consolidated Statement of Comprehensive Income of stress testing the period end goodwill valuation with a decrease in revenues of 10% and an increase in cost of equity discount rate of 3%. These potential changes in key assumptions fall within historic variations experienced by the business (taking other factors into account) and are therefore deemed reasonable. The current model reveals that a sustained decrease in revenue of circa 20% for Jersey and circa 25% for Gibraltar or a sustained increase of circa 8% in the cost of Equity discount rate for Jersey and circa 12% for Gibraltar would remove the headroom. The model assumes that the downturn relating to Covid-19 is a temporary downturn and that once things get back to normal, activity in each of Jersey and Gibraltar will get back to more normal levels within a year. Should the recovery be delayed due to Covid-19, Brexit or some other factor then there is a heightened risk that headroom in either model could be substantially affected and may result in an impairment of goodwill.

 

Sensitivity Applied

 

Reduction in headroom implied by sensitivity

 

 

 

 

Sancus

Jersey

 £'000

Sancus

Gibraltar

 £'000

 

Total

£'000

 

 

 

 

 

 

10% decrease in revenue per annum

 

5,526

3,359

8,885

3% increase in cost of Equity discount rate

 

5,054

3,091

8,145

 

Neither a 10 % decrease in revenue nor a 3% increase in the cost of Equity discount rate implies a reduction of Goodwill in Jersey or Gibraltar.

 

 

11. OTHER INTANGIBLE ASSETS

 

 

£'000

Cost

 

At 30 June 2020 and 31 December 2019

1,584

 

 

Amortisation

 

At 31 December 2019

1,250

Charge for the period

83

At 30 June 2020

1,333

 

 

Net book value at 30 June 2020

251

 

 

Net book value at 31 December 2019

334

 

 

Intangible assets comprise capitalised contractors' costs and costs related to core systems development. No impairment provision has been recorded. The amortisation charge has been recorded within Operating Expenses.

 

 

12. TRADE AND OTHER RECEIVABLES

 

30 June 2020

(unaudited)

 

31 December 2019

(audited)

 

Current

£'000

£'000

Dividend income receivable

68

68

Loan fees and similar receivable

1,608

1,093

Loan interest receivable

6,140

4,047

Receivable from associated companies

42

13

Derivative contracts (note 18)

-

156

Other trade receivables and prepaid expenses

730

532

 

8,588

5,909

 

13. OTHER ASSETS

 

 

Properties held for sale

Development properties

 

Total

Cost

£'000

£'000

£'000

At 31 December 2018

1,377

3,027

4,404

Transfers

(509)

509

-

Additions

17

787

804

Disposals

(885)

-

(885)

Write down

-

(987)

(987)

At 31 December 2019

-

3,336

3,336

 

 

 

 

Additions

-

147

147

Write down

-

(983)

(983)

Disposals

-

(1,598)

(1,598)

At 30 June 2020

-

902

902

 

Other assets are developments which were previously held as security against certain loans which have defaulted. These assets are held at the lower of cost and net realisable value.

 

 

14. SHARE CAPITAL, SHARE PREMIUM & DISTRIBUTABLE RESERVE

 

GLI Finance Limited has the power under its articles of association to issue an unlimited number of Ordinary Shares of nil par value.

 

No Ordinary Shares were issued in the period to 30 June 2020 (Period to 30 June 2019: Nil).

 

Share Capital

 

 

Number of Ordinary Shares - nil par value

 

At 30 June 2020 (unaudited) and 31 December 2019 (audited)

312,065,699

 

 

Share Premium

 

 

Ordinary Shares - nil par value

£'000

At 30 June 2020 (unaudited) and 31 December 2019 (audited)

112,557

 

 

Treasury Shares

 

As at 30 June 2020 and 31 December 2019 a total of 7,925,999 Ordinary Shares, with an aggregate value of £1,098,814 were held by a Subsidiary, Sancus BMS Group Limited ("SBMSGL") and eliminated on consolidation.

 

 

30 June 2020

(unaudited)

31 December 2019

(audited)

 

£'000

£'000

Balance at start of the period/year

1,099

1,162

GLI shares transferred by SBMSGL to key members of management

-

(399)

GLI shares purchased by SBMSGL from BMS management

-

336

Balance at end of period/year

1,099

1,099

 

Warrants in Issue

 

On 25 February 2016, Shareholders approved special resolutions authorising the issue of warrants to Golf Investments Limited which confer the warrant holder the right to subscribe for up to 32,000,000 new Ordinary Shares in the capital of the Company at the following subscription prices:

 

10,000,000 Ordinary Shares at 40 pence per Ordinary Share;

10,000,000 Ordinary Shares at 45 pence per Ordinary Share;

12,000,000 Ordinary Shares at 55 pence per Ordinary Share.

 

These warrants expired on 25 February 2020.

 

On 16 September 2016, Shareholders approved a special resolution authorising the issue of warrants to Golf Investments Limited which confer the warrant holder the right to subscribe for up to 10,000,000 shares at 37 pence per Ordinary Share, exercisable up to 9 August 2020.

 

None of the above warrants were exercised prior to their expiry dates and therefore all have now expired.

 

 

15. LIABILITIES

 

 

Non-current liabilities

30 June 2020

(unaudited)

31 December 2019

(audited)

 

£'000

£'000

Corporate bond (1)

-

10,000

HIT facility (2)

-

44,191

Lease Creditor

576

679

Total non-current liabilities

576

54,870

 

 

Current liabilities

30 June 2020 (unaudited)

31 December 2019 (audited)

 

£'000

£'000

Corporate Bond (1)

10,000

-

HIT facility (2)

40,748

-

ZDP shares (3)

12,604

16,825

Accounts payable

251

91

Accruals and other payables

 928

1,404

Tax payable

188

221

Deferred income

67

5

Derivative contracts (note 18)

307

-

Lease creditor

180

211

Total current liabilities

65,273

18,757

 

Interest costs on debt facilities

 

 

 

30 June 2020

(unaudited)

30 June 2019

(unaudited)

 

£'000

£'000

Corporate bond (1)

348

347

HIT Facility (2)

1,836

1,340

ZDP Shares (3)

726

530

Lease interest

30

18

Total interest cost on debt facilities

2,940

2,235

 

 

(1) Corporate Bond

 

On 30 June 2016, GLI Finance issued £10m corporate bonds as part of the acquisition of Sancus Gibraltar. The bond maturity date is 30 June 2021 and they bear interest at 7% (2019: 7%). This has been moved to current liabilities as it matures within one year of the balance sheet date.

 

(2) HIT Facility

 

On 29 January 2018, GLI Finance signed a new funding facility with Honeycomb Investment Trust plc (HIT). The funding line has a term of 3 years and comprises a £45m accordion and revolving credit facility. The facility bears interest at 7.25%. This has been moved to current liabilities as it matures within one year of the balance sheet date.

 

The HIT facility has portfolio performance covenants including that actual loss rates are not to exceed 4% in any twelve month period and underperforming loans are not to exceed 10% of the portfolio.

 

Sancus BMS Group has a £5m first loss position on the HIT facility. GLI has also provided HIT with a guarantee, capped at £2m that will continue to ensure the orderly wind down of the loan book, in the event of the insolvency of Sancus BMS Group, given its position as facility and security agent.

 

 

(3) ZDP shares

 

The ZDP shares have a maturity date of 5 December 2020 with a final capital entitlement of £1.4115 per ZDP share, and bear interest at an average rate of 8.0% (2019: 5.5%).

 

Refer to the Company's Memorandum and Articles of Incorporation for full detail of the rights attached to the ZDP shares. This document can be accessed via the Company's website www.glifinance.com.

 

In accordance with article 7.5.5 of the Company's Memorandum and Articles of Incorporation, the Company may not incur more than £30m of long term debt without the prior approval from the ZDP shareholders. The Memorandum and Articles also specify that two debt cover tests must be met in relation to the ZDPs. At 30 June 2020 the Company was in compliance with these covenants as Cover Test A was 4.84 (minimum of 1.7) and Cover Test B was 4.84 (minimum of 3.25).

 

At the period end senior debt borrowing capacity amounted to £20m. The HIT facility does not impact on this capacity as this is non-recourse to GLI.

 

 

16. NOTES TO THE CASH FLOW STATEMENT

 

Cash outflow from operations (excluding loan movements)

 

30 June 2020

(unaudited)

30 June 2019

(unaudited)

 

 

£'000

£'000

 

 

 

 

Loss for the period

 

(6,515)

(6,136)

 

 

 

 

Adjustments for:

 

 

 

 

 

 

 

Net loss on FinTech Ventures

 

4,238

5,166

Other net (gains) / losses

 

(147)

393

Adjustment in carrying value of Sancus IOM Holdings Limited

 

755

-

Accrued interest on ZDPs

 

554

530

Impairment of financial assets

 

253

1,175

Impairment / loss on sale of SPL assets

 

983

567

Gain on purchase of ZDPs

 

(44)

(308)

Amortisation / depreciation of fixed assets

 

216

263

Amortisation of debt issue costs

 

96

56

 

 

 

 

Changes in working capital:

 

 

 

Trade and other receivables

 

(3,272)

(2,710)

Trade and other payables

 

60

(856)

 

 

 

 

Cash outflow from operations, excluding loan movements

 

(2,823)

(1,860)

 

 

 

 

 

Changes in liabilities arising from financing activities

 

The table below details changes in the Group's liabilities arising from financing activities, including both cash and non-cash changes. Liabilities arising from financing activities are those for which cash flows were, or future cash flows will be classified in the Group's consolidated cash flow statement as cash flows from financing activities.

 

 

1 January 2020

Financing cash flows1

 

 

Loan swap Non-cash

Amortisation of debt issue costs

Non-cash

Other

Non-cash

30 June 2020

 

£'000

£'000

£'000

£'000

£'000

£'000

 

 

 

 

 

 

 

ZDP Shares

16,825

(3,942)

(829)2

40

5103

12,604

Corporate Bond

10,000

-

-

-

-

10,000

HIT Facility

44,191

(3,499)

-

56

-

40,748

Lease Liability

890

(128)

-

-

(6)4

756

Total liabilities from financing activities

71,906

(7,569)

(829)

96

504

64,108

 

 

1 January 2019

Financing cash flows1

 

 

Additions Non-cash

Amortisation of debt issue costs

Non-cash

Interest Accruals

Non-cash

30 June 2019

 

£'000

£'000

£'000

£'000

£'000

£'000

 

 

 

 

 

 

 

ZDP Shares

24,059

(4,290)

-

-

2223

19,991

Corporate Bond

10,000

-

-

-

-

10,000

HIT Facility

22,684

9,706

-

56

-

32,446

Lease Liability

847

(94)

233

-

-

986

Total liabilities from financing activities

57,590

5,322

233

56

222

63,423

 

1These amounts can be found under financing cash flows in the cash flow statement.

2 A loan to the value of £829,000 which sat within Sancus BMS loans and loan equivalents was swapped for 621,586 ZDP shares.

3 Interest accruals.

4 Lease variation.

 

17. RELATED PARTY TRANSACTIONS

 

 

Transactions with the Directors/Executive Team

 

Non-executive Directors

 

As at 30 June 2020, the non-executive Directors' annualised fees, excluding all reasonable expenses incurred in the course of their duties which were reimbursed by the Company, were as detailed in the table below:

 

 

 

30 June 2020

 

30 June 2019

 

£

 

£

 

 

 

 

Patrick Firth (Chairman)

50,000

 

50,000

John Whittle

42,500

 

42,500

Nick Wakefield

35,000

 

35,000

 

 

 

 

 

 

On 4 June 2019 Mr Wakefield was appointed as a non-executive Director to the Board. Mr Wakefield's directorships were listed in the RNS issued on 5 June 2019. Golf Investments Limited ("Golf"), of which Mr Wakefield is a Director, holds 50,815,167 ordinary shares in the Company. Golf is part of the Somerston Group of companies which collectively holds 83,017,496 ordinary shares in the Company, representing 26.6 per cent of the current issued share capital. From time to time, the Somerston Group may participate as a Co-Funder in Sancus BMS loans. Other than this and the Directors' fees and expenses in relation to Mr Wakefield's appointment as a Director the Group has not recorded any transactions with either Golf or Somerston for the period ended 30 June 2020 (30 June 2019: none).

 

There was no increase in the other Directors' base fees during the period ended 30 June 2020. Total Directors' fees charged to the Company for the period ended 30 June 2020 were £63,750 (30 June 2019: £48,839). From 1 July 2020 Directors' fees will be reduced by 10% as part of Covid-19 cost saving initiatives.

 

 

Executive Team

 

For the period ended 30 June 2020, the Executive Team members' remuneration from the Company, excluding all reasonable expenses incurred in the course of their duties which were reimbursed by the Company, were as detailed in the table below:

 

 

30 June 2020

30 June 2019

 

£'000

£'000

 

 

 

Aggregate remuneration in respect of qualifying service - fixed salary

343

364

Aggregate amounts contributed to Money Purchase pension schemes

47

51

 

 

All amounts have been charged to Operating Expenses.

 

From 1 July 2020 all staff have taken a pension holiday (except for statutory minimums) until further notice as part of Covid-19 cost saving initiatives.

 

Directors' and Persons Discharging Managerial Responsibilities ("PDMR") shareholdings in the Company

 

As at 30 June 2020, the Directors had the following beneficial interests in the Ordinary Shares of the Company:

 

 

30 June 2020

31 December 2019

 

No. of Ordinary Shares Held

% of total issued Ordinary Shares

No. of Ordinary Shares Held

% of total issued Ordinary Shares

 

 

 

 

 

Patrick Firth (Chairman)

278,669

0.09

278,669

0.09

John Whittle

104,550

0.03

104,550

0.03

Andrew Whelan

9,553,734

3.06

9,553,734

3.06

Emma Stubbs

1,380,940

0.44

1,380,940

0.44

Dan Walker

911,300

0.29

911,300

0.29

Nick Wakefield

-

-

-

-

 

In the six month period to June 2020 and the year to December 2019, none of the above received any amounts relating to their shareholding.

 

During the period Mr Whelan received £27,847 in relation to the coupon on his holding of £800,000 GLI Bonds (30 June 2019: £20,567).

 

 

Transactions with connected entities

 

The following significant transactions with connected entities took place during the current period:

 

 

 

30 June 2020

30 June 2019

 

Balance

£'000

Interest accrued in the period

Balance

£'000

 

Interest

accrued in

 the period

 

 

£'000

 

£'000

 

 

 

 

 

Loans (and corresponding interest receivable) to entities in which GLI Group has a significant stake

1,853

82

2,201

174

 

Preference shares (and corresponding interest receivable) in entities which GLI Group has a significant stake

-

-

-

129

 

 

Receivable from related parties

 

 

30 June

2020

31 December 2019

 

 

 

 

£'000

£'000

 

Sancus (IOM) Limited

 

 

32

1

 

Amberton Asset Management

 

 

10

12

 

 

 

 

Office and staff costs recharges

 

 

 

30 June 2020

30 June 2019

 

Amberton Asset Management

20

17

 

       

 

There is no ultimate controlling party of the Company.

All platform loans and preference shares bear interest at a commercial rate.

 

 

18. FINANCIAL INSTRUMENTS - Fair values and risk management

 

 

Sancus BMS loans and loan equivalents

 

 

30 June 2020 (unaudited)

31 December 2019 (audited)

Non-current

£'000

£'000

 

 

 

Sancus BMS loans

366

3,099

Sancus Loans Limited loans

3,616

5,851

Total Non-current Sancus BMS loans and loan equivalents

3,982

8,950

 

 

 

Current

 

 

 

 

 

Sancus BMS loans

13,767

15,145

Loan equivalents

104

103

Sancus Loans Limited loans

37,552

40,034

Total Current Sancus BMS loans and loan equivalents

51,423

55,282

 

 

 

Total Sancus BMS loans and loan equivalents

55,405

64,232

 

 

 

Fair Value Estimation

 

 

The financial assets and liabilities measured at fair value in the Consolidated Statement of Financial Position are grouped into the fair value hierarchy as follows:

 

 

30 June 2020

(unaudited)

31 December 2019 (audited)

 

Level 2

Level 3

Level 2

Level 3

 

£'000

£'000

£'000

£'000

 

 

 

 

 

Fintech Ventures investments

-

2,164

-

6,299

Derivative contracts

(307)

-

156

-

Total assets / liabilities at fair value

(307)

2,164

156

6,299

 

 

The classification and valuation methodology remains as noted in the 2019 Annual Report.

 

In relation to the Level 3 valuation methodology for the FinTech Ventures investments the Board assesses the fair value based on either the value at the last capital transaction or valuation techniques, performed internally or by an independent third-party expert. Factors considered in these valuation analyses include comparable company and comparable transaction analysis based on recent fundraising activity. The Board considers all the information presented to it, including indicative bids, internal analysis, and independent valuations, in order to reach, in good faith, their value determination. In other cases cost, adjusted for FX movement and new investment etc, is used to determine fair value.

 

 

Assets at Amortised Cost

 

30 June 2020

31 December 2019

 

(unaudited)

(audited)

 

£'000

£'000

 

 

 

Sancus BMS loans and loan equivalents

55,405

64,232

Loans through platforms

21

31

Trade and other receivables

8,588

5,753

Cash and cash equivalents

6,621

7,244

Total assets at amortised cost

70,635

77,260

 

 

Liabilities at Amortised Cost

 

30 June 2020

31 December 2019

 

(unaudited)

(audited)

 

£'000

£'000

 

 

 

ZDP shares

12,604

16,825

Corporate Bond

10,000

10,000

HIT facility

40,748

44,191

Trade and other payables

1,434

1,721

Lease creditor

756

890

Total liabilities at amortised cost

65,542

73,627

 

Refer to Note 15 for further information on liabilities.

 

 

 

FinTech Ventures Investments

 

 

Total Portfolio

30 June 2020

£

 

 

At 31 December 2019

6,299

Net new investments / divestments

49

Unrealised gains / (losses) recognised in profit and loss

(4,238)

Foreign exchange gain

54

At 30 June 2020

2,164

 

 

 

 

Total Portfolio

31 December 2019

£

 

 

At 31 December 2018

13,804

New investments / loans advanced

38

Unrealised losses recognised in profit and loss

(7,493)

Foreign exchange loss

(50)

At 31 December 2019

6,299

 

 

 

 

Credit Risk

 

Credit risk is defined as the risk that a borrower/debtor may fail to make required repayments within the contracted timescale. The group invests in senior debt, senior subordinated debt, junior subordinated debt and secured loans. Credit risk is taken in direct lending to third party borrowers, investing in loan funds, lending to associated platforms and loans arranged by associated platforms. The group mitigates credit risk by only entering into agreements related to loan instruments in which there is sufficient security held against the loans or where the operating strength of the investee companies is considered sufficient to support the loan amounts outstanding.

 

Credit risk is determined on initial recognition of each loan and re-assessed at each balance sheet date. It is categorized into Stage 1, Stage 2 and Stage 3 with Stage 1 being to recognise 12 month Expected Credit Losses (ECL), Stage 2 being to recognise Lifetime ECL not credit impaired and Stage 3 being to recognise Lifetime ECL credit impaired.

 

 

Foreign Exchange Risk - Derivative instruments

 

The Treasury Committee Team monitors the Group's currency position on a regular basis, and the Board of Directors reviews it on a quarterly basis. Loans denominated in Euros which are taken out through the HIT facility are hedged. Forward contracts to sell Euros at loan maturity dates are entered into when loans are drawn in Euros. At 30 June 2020 the following forward foreign exchange contracts were open:

 

 

June 2020

 

 

 

 

 

 

 

Counterparty

Settlement date

Buy Currency

Buy Amount £'000

Sell currency

Sell amount €'000

Unrealised loss £'000

 

 

 

 

 

 

 

EWealthGlobal Group Limited

 September 2020 to March 2021

GBP

3,346

Euro

3,883

(182)

 

 

 

 

 

 

 

Liberum Wealth Limited

January 2021 to

June 2021

GBP

2,585

Euro

2,953

(125)

 

 

 

 

 

 

 

Unrealised loss on forward foreign contracts

(307)

 

 

December 2019

 

 

 

 

 

 

 

 

 

 

 

 

Counterparty

Settlement date

Buy Currency

Buy Amount £'000

Sell currency

Sell amount €'000

Unrealised gain £'000

 

 

 

 

 

 

 

EWealthGlobal Group Limited

 December 2020 to January 2021

GBP

2,252

Euro

2,590

38

 

 

 

 

 

 

 

Liberum Wealth Limited

February 2020 to November 2020

GBP

3,467

Euro

3,951

118

 

 

 

 

 

 

 

Unrealised gain on forward foreign contracts

156

 

No hedging has been taken out against investments in the FinTech Ventures platforms (2019: £Nil).

 

 

Provision for ECL

 

Provision for ECL is made using the credit risk, the probability of default (PD) and the probability of loss given default (PL) all of which are underpinned by the Loan to Value (LTV), historical position, forward looking considerations and on occasion, subsequent events and the subjective judgement of the Board. Preliminary calculations for ECL are performed on a loan by loan basis using the simple formula: Outstanding Loan Value x PD x PL and are then amended as necessary according to the more subjective measures as noted above.

 

A probability of default is assigned to each loan. This probability of default is arrived at by reference to historical data and the ongoing status of each loan which is reviewed on a regular basis. The probability of loss is arrived at with reference to the LTV and consideration of cash that can be redeemed on recovery.

 

 

 

Movement of provision for ECL in the period

 

30 June

 2020

31 December 2019

 

£'000

£'000

At beginning of period / year

2,868

2,597

(Credited) / Charged through profit and loss in the period / year

(92)

1,212

Utilised in the period / year

92

(941)

At end of period / year

2,868

2,868

 

In addition to the above £253,000 has been provided against Trade debtors giving a total ECL charge for the period to June 2020 of £161,000.

 

19. GUARANTEES

 

 

The Group undertakes a number of Guarantees and first loss positions which are not deemed to be contingent liabilities under IAS37 as there is no present obligation for these guarantees and it is considered unlikely that these liabilities will crystallise.

 

HIT Facility

Sancus BMS Group has invested £5m of its own capital in Sancus Loans Limited which sits in a £5m first loss position as part of the HIT facility. GLI has also provided HIT with a guarantee, capped at £2m that it will continue to ensure the orderly wind down of the HIT related loan book, in the event of the insolvency of Sancus BMS Group, given its position as facility and security agent.

 

Sancus Loan Notes

SLN5, launched in 2018, currently stands at £19.6m. Sancus BMS has a 10% first loss position on this loan note. SLN6, launched in 2019, currently stands at £4.4m. Sancus BMS has no first loss position on this loan note. No other Loan notes are currently in existence.

 

Commitments

As at 30 June 2020 the Group has unfunded commitments of £24.2m (31 December 2019: £21.4m). These unfunded commitments primarily represent the undrawn portion of development finance facilities. Drawdowns are conditional on satisfaction of specified conditions precedent, including that the borrower is not in breach of its representations or covenants under the loan or security documents. The figure quoted is the maximum exposure assuming that all such conditions for drawdown are met. Directors expect the majority of these commitments to be filled by Co-Funders.

 

 

20. PERFORMANCE MEASURES

 

We have identified the below performance measures which for Sancus BMS we will report on as we believe improving these will improve shareholder value.

 

Return on Tangible Assets ("ROTA")

 

This is Sancus BMS net operating profit (after IFRS9 adjustments) divided by Sancus BMS total assets less Goodwill and HIT.

 

Sancus BMS

June 2020

December 2019

Net operating profit (Note 3)

£0.1m

£0.4m

Total Assets less Goodwill and HIT

£36.1m

£42.6m

Return on Tangible Assets

0.5%

0.9%

 

Cost Income Ratio

 

Total costs include, operating expenses, debt costs, broker costs and IFRS9 adjustments, divided by proforma revenue.

 

Sancus BMS

June 2020

December 2019

Total Costs

£3.5m

£9.3m

Proforma revenue

£3.6m

£9.6m

Cost Income Ratio

97.5%

96.1%

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR ZBLFXBKLXBBE
Date   Source Headline
11th May 20216:08 pmRNSAppointment of Independent Non-Executive Director
11th May 202111:30 amRNSResults of AGM and Change of Company Name
4th May 20211:40 pmRNSTransaction in Own Shares & Total Voting Rights
30th Apr 20217:00 amRNSTransaction in Own Shares & Total Voting Rights
22nd Apr 202111:09 amRNSResult of Extraordinary General Meeting
20th Apr 20215:17 pmRNSNotice of AGM and Proposed Change of Company Name
1st Apr 20217:00 amRNSTender Offer of ZDP Shares and Notice of EGM
31st Mar 20217:00 amRNSFinal Results for the Year Ended 31 December 2020
22nd Mar 20217:00 amRNSTransaction in Own Shares & Total Voting Rights
18th Mar 20217:00 amRNSTransaction in Own Shares & Total Voting Rights
2nd Mar 20217:00 amRNSTransaction in Own Shares & Total Voting Rights
26th Feb 20215:17 pmRNSZDP Tender Offer Update and Buyback Programme
31st Dec 202012:15 pmRNSTotal Voting Rights, Issue of Bonds and Warrants
23rd Dec 202011:31 amRNSTR-1: Notification of Major Holdings
8th Dec 20207:00 amRNSDirector/ PDMR Dealing
4th Dec 20202:28 pmRNSResult of Shareholder Meetings and Fundraising
17th Nov 20207:00 amRNSProposed Refinancing
16th Oct 202011:04 amRNSTransaction in Own Shares & Total Voting Rights
16th Oct 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
15th Oct 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
9th Oct 20209:01 amRNSZDP Share Buy-Back Programme
30th Sep 20203:44 pmRNSInterim Results
6th Aug 20204:44 pmRNSTR1: Notification of Major Holdings
3rd Jul 202012:13 pmRNSTR-1: Notification of Major Holdings
25th Jun 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
17th Jun 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
12th May 20201:57 pmRNSResults of Annual General Meeting
7th May 20208:35 amRNSTR-1: Notification of Major Holdings
7th May 20208:29 amRNSTR-1: Notification of Major Holdings
28th Apr 20205:39 pmRNSDisclosure of rights attached to shares
21st Apr 20205:27 pmRNSAnnual Report and Notice of AGM
7th Apr 20207:00 amRNSFinal Results for the Year Ended 31 December 2019
6th Mar 202011:58 amRNSResult of EGM and Tender Offer
4th Mar 20203:19 pmRNSTR-1: Notification of Major Holdings
4th Mar 20203:12 pmRNSTR-1: Notification of Major Holdings
18th Feb 20207:00 amRNSTender Offer
4th Feb 20207:00 amRNSTrading Update
19th Dec 201910:57 amRNSTR-1: Notification of Major Holdings
8th Nov 20193:10 pmRNSResults of Class Meetings and EGM
4th Nov 20195:27 pmRNSTR-1: Notification of Major Holdings
21st Oct 20198:24 amRNSProposals for the Continuation of the ZDP Shares
18th Sep 20197:00 amRNSInterim Results for the six months to 30 June 2019
28th Aug 20197:00 amRNSTransaction in Own Shares & Total Voting Rights
23rd Aug 20197:00 amRNSTransaction in Own Shares & Total Voting Rights
22nd Aug 20197:00 amRNSTransaction in Own Shares & Total Voting Rights
20th Aug 20197:00 amRNSTransaction in Own Shares & Total Voting Rights
16th Aug 20197:00 amRNSTransaction in Own Shares & Total Voting Rights
9th Aug 20197:00 amRNSTransaction in Own Shares & Total Voting Rights
6th Aug 20197:00 amRNSTransaction in Own Shares & Total Voting Rights
29th Jul 20197:00 amRNSTransaction in Own Shares & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.